Digital Therapeutics – New Trends and Role of Care

There is an evolution occurring in how digital technology is advancing and being used to support the delivery of mental and behavioral health care. The COVID-19 pandemic brought mental health and gaps in mental health care to the forefront in the areas of depression and substance use disorders. Digital therapeutics represent one potential tool that can be used to address these gaps in care. By the end of this session, participants will demonstrate an understanding of common mental health issues facing the American workforce and how digital therapeutics can help to address these issues.

This program is pending approval for 1.5 credit hours for EACC professional development via EAPA.

Guest Speaker

Quentin O’Brien, MPH, NREMT

Medical Science Liaison, Digital Therapeutics at Orexo US, Inc.

Objectives of Speaker Session:

• Participants will be able to demonstrate an understanding of depression, problematic drinking, and opioid use disorder, and how these mental health issues impact the workforce.

• Participants will be able to describe digital therapeutics in the mental health space, and they will be able to use deprexis as an example of just one mental health digital therapeutic.

• Participants will be able to assess the clinical data supporting the use of digital therapeutics with a particular focus on Orexo’s digital therapeutics deprexis® and vorvida®.

Summary of Session:

1. Overview of depression, problematic drinking, and opioid use disorder

2. Introduction to digital therapeutics for mental health

3. Demonstration of deprexis®, a digital therapeutic for depression

4. Clinical data to support the use of digital therapeutics

5. Question and answer session

About our Speaker

QUENTIN O’BRIEN, MPH, NREMT

Based in Morristown, NJ

Education:

George Washington University

Doctor of Philosophy (PhD), Translational Health Sciences (Expected May 2022)

• Dissertation: Exploring Client Satisfaction with Videoconferencing Psychotherapy Among Diverse Populations: A Mixed Methods Study

Washington, DC (remote)

Mailman School of Public Health, Columbia University

Master of Public Health (MPH) New York, NY May 2015

Rensselaer Polytechnic Institute (RPI)

Bachelor of Science (BS), Environmental Science, Concentration in Biology Troy, NY May 2013

Work Experience:

Orexo US, Inc. ; Medical Science Liaison, Digital Therapeutics

Mallinckrodt Pharmaceuticals ; Medical Science Liaison, Immune Cell Therapy, Scientific Communications Manager, Immune Cell Therapy

Alfasigma USA ; Medical Affairs Manager

Health and Wellness Partners; Associate Scientific Director, Associate Director of Client Services

Professional Memberships:

• American Psychological Association (APA)

• American Public Health Association (APHA)

• International Society of Medical Publications Professionals (ISMPP)

Publications:

Graziose MM, Downs SM, O’Brien Q, Fanzo J. Systematic review of the design, implementation and effectiveness of mass media and nutrition education interventions for infant and young child feeding. Public Health Nutr. 2018;21(2):273-287.

Conference Presentations:

Messina AJ, O’Brien QE, Andrianov V, Moss KR, Vidal-Fisher L. Under Reporting of Patient Reported

Outcomes (PROs) in Myeloproliferative Neoplasm (MPN) Clinical Trials. Poster presented at: 61st Annual Meeting of the American Society of Hematology; December 2019; Orlando, FL.

O’Brien QE, Lotrecchiano GR. Applying Team Science Principles to Biomedical Publications Teams: Understanding Team Effectiveness. Poster presented at: 10th Annual International Science of Team Science Conference; May 2019; Lansing, MI.

O’Brien QE, Scully J, Hegarty J. Understanding primary care providers’ and general neurologists’ interest in and need for education on Alzheimer’s Disease management. Poster presented at: 46th North American Primary Care Research Group (NAPCRG) Annual Meeting; November 2018; Chicago, IL.

Mattingly G, Jain R, O’Brien QE, Hegarty J. Investigation of Clinical Practice Challenges in the Management of ADHD. Poster presented at: American Professional Society of ADHD and Related Disorders; January 2018; Washington, DC.

O’Brien QE, Scully J, Rappa E, Smith PK, Hegarty J. Defining the Need for Better Tools and Education on Tacrolimus Intrapatient Variability to Improve Outcomes for Transplant Patients. Poster presented at: American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; December 2017; Orlando, FL.

Jain R, Mattingly G, Pikalov A, O’Brien QE, Scully J, Smith L, Sender D, O’Brien K, Hegarty J. Unmet Needs in the Treatment of Pediatric and Adult ADHD. Poster presented at: Psych Congress; September 2017; New Orleans, LA.

O’Brien QE, Smith PK, Sender D, Hegarty J. Practice Perspectives on Telepsychiatry Use. Poster presented at: U.S. Psychiatric and Mental Health Congress; October 2016; San Antonio, TX.

O’Brien QE, Downs S, Graziose M, Fanzo J. Assessing Nutrition Knowledge Gaps and IYCF Practices of Mothers in Rural Senegal: A Formative Assessment for Nutrition Education. Oral presentation at: Mailman School of Public Health Student Research Diversity Day; May 2015; New York, NY.

Image Source Credit: www.whatech.com